Preparation and characterization of vancomycin releasing PHBV coated 45S5 Bioglass®-based glass-ceramic scaffolds for bone tissue engineering

Journal of the European Ceramic Society

Volumn 34, Issue 2, 2014, Pages 505-514

  Li, Wei ^a   Nooeaid, Patcharakamon ^a   Roether, Judith A ^a   Schubert, Dirk W ^a   Boccaccini, Aldo R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

45S5 Bioglass ; Drug release; Mechanical properties; PHBV; Scaffold

Indexed keywords

45S5 BIOGLASS; BIOACTIVE COMPOSITES; BONE TISSUE ENGINEERING; DRUG RELEASE; ENCAPSULATED DRUGS; INTERCONNECTED PORES; PHBV; REPLICATION METHOD;

BONE; COATINGS; GLASS; MECHANICAL PROPERTIES; SCAFFOLDS; SECONDARY BATTERIES;

SCAFFOLDS (BIOLOGY);

EID: 84887177861     PISSN: 09552219     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jeurceramsoc.2013.08.032     Document Type: Article

References (49)

1. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260:920-926.
2. Rahaman M.N., Day D.E., Sonny Bal B., Fu Q., Jung S.B., Bonewald L.F., et al. Bioactive glass in tissue engineering. Acta Biomater 2011, 7:2355-2373.
3. Rezwan K., Chen Q.Z., Blaker J.J., Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006, 27:3413-3431.
4. Baino F., Vitale-Brovarone C. Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future. J Biomed Mater Res A 2011, 97A:514-535.
5. Gorustovich A.A., Roether J.A., Boccaccini A.R. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B: Rev 2010, 16:199-207.
6. Chen Q.Z., Thompson I.D., Boccaccini A.R. 45S5 Bioglass (R)-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 2006, 27:2414-2425.
7. Peroglio M., Gremillard L., Chevalier J., Chazeau L., Gauthier C., Hamaide T. Toughening of bio-ceramics scaffolds by polymer coating. J Eur Ceram Soc 2007, 27:2679-2685.
8. 3 scaffolds by poly(d,l-lactic acid) modification. Acta Biomater 2008, 4:343-353.
9. Kim H.W., Knowles J.C., Kim H.E. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release. J Mater Sci Mater Med 2005, 16:189-195.
10. Yunos D.M., Bretcanu O., Boccaccini A.R. Polymer-bioceramic composites for tissue engineering scaffolds. J Mater Sci 2008, 43:4433-4442.
11. Dressler M., Dombrowski F., Simon U., Börnstein J., Hodoroaba V.D., Feigl M., et al. Influence of gelatin coatings on compressive strength of porous hydroxyapatite ceramics. J Eur Ceram Soc 2011, 31:523-529.
12. Chen Q.Z., Boccaccini A.R. Poly(d,l-lactic acid) coated 45S5 Bioglass (R)-based scaffolds: processing and characterization. J Biomed Mater Res A 2006, 77A:445-457.
13. Yang G., Yang X., Zhang L., Lin M., Sun X., Chen X., et al. Counterionic biopolymers-reinforced bioactive glass scaffolds with improved mechanical properties in wet state. Mater Lett 2012, 75:80-83.
14. ®-based scaffolds incorporating polycaprolactone and chitosan coatings for controlled vancomycin delivery. Ceram Int 2013, 39:7517-7522.
15. Erol M., Ozyuguran A., Ozarpat O., Kucukbayrak S. 3D composite scaffolds using strontium containing bioactive glasses. J Eur Ceram Soc 2012, 32:2747-2755.
16. Mourino V., Boccaccini A.R. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 2010, 7:209-227.
17. Cartmell S. Controlled release scaffolds for bone tissue engineering. J Pharm Sci 2009, 98:430-441.
18. Habraken W., Wolke J.G.C., Jansen J.A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007, 59:234-248.
19. Misra S.K., Valappil S.P., Roy I., Boccaccini A.R. Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 2006, 7:2249-2258.
20. Pouton C.W., Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Deliv Rev 1996, 18:133-162.
21. Williams S.F., Martin D.P., Horowitz D.M., Peoples O.P. PHA applications: addressing the price performance issue I. Tissue engineering. Int J Biol Macromol 1999, 25:111-121.
22. Coimbra P.A., De Sousa H.C., Gil M.H. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul 2008, 25:170-178.
23. Goodman S.B., Yao Z., Keeney M., Yang F. The future of biologic coatings for orthopaedic implants. Biomaterials 2013, 34:3174-3183.
24. Cabanas M.V., Pena J., Roman J., Vallet-Regi M. Tailoring vancomycin release from beta-TCP/agarose scaffolds. Eur J Pharm Sci 2009, 37:249-256.
25. Zhou J., Fang T., Wang Y., Dong J. The controlled release of vancomycin in gelatin/beta-TCP composite scaffolds. J Biomed Mater Res A 2012, 100:2295-2301.
26. Kankilic B., Bayramli E., Kilic E., Dagdeviren S., Korkusuz F. Vancomycin containing PLLA/beta-TCP controls MRSA in vitro. Clin Orthop Relat Res 2011, 469:3222-3228.
27. Hench L.L. Bioceramics. J Am Ceram Soc 1998, 81:1705-1728.
28. Kokubo T., Ito S., Huang Z., Hayashi T., Sakka S., Kitsugi T., et al. Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 1990, 24:331-343.
29. Boyan B.D., Hummert T.W., Dean D.D., Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 1996, 17:137-146.
30. Bretcanu O., Misra S., Roy I., Renghini C., Fiori F., Boccaccini A.R., et al. In vitro biocompatibility of 45S5 Bioglass (R)-derived glass-ceramic scaffolds coated with poly(3-hydroxybutyrate). J Tissue Eng Regen Med 2009, 3:139-148.
31. Pezzotti G., Asmus S.M.F. Fracture behavior of hydroxyapatite/polymer interpenetrating network composites prepared by in situ polymerization process. Mater Sci Eng A: Struct Mater 2001, 316:231-237.
32. Nalla R.K., Kinney J.H., Ritchie R.O. Mechanistic fracture criteria for the failure of human cortical bone. Nat Mater 2003, 2:164-168.
33. Athanasiou K.A., Zhu C.F., Lanctot D.R., Agrawal C.M., Wang X. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng 2000, 6:361-381.
34. Bretcanu O., Chatzistavrou X., Paraskevopoulos K., Conradt R., Thompson I., Boccaccini A.R. Sintering and crystallisation of 45S5 Bioglass (R) powder. J Eur Ceram Soc 2009, 29:3299-3306.
35. Xin R., Zhang Q., Gao J. Identification of the wollastonite phase in sintered 45S5 bioglass and its effect on in vitro bioactivity. J Non Cryst Solids 2010, 356:1180-1184.
36. Qian J.M., Kang Y.H., Wei Z.L., Zhang W. Fabrication and characterization of biomorphic 45S5 bioglass scaffold from sugarcane. Mater Sci Eng C: Mater Biol Appl 2009, 29:1361-1364.
37. Aguilar-Reyes E.A., León-Patiño C.A., Jacinto-Diaz B., Lefebvre L.-P. Structural characterization and mechanical evaluation of bioactive glass 45S5 foams obtained by a powder technology approach. J Am Ceram Soc 2012, 95:3776-3780.
38. Lefebvre L., Gremillard L., Chevalier J., Zenati R., Bernache-Assolant D. Sintering behaviour of 45S5 bioactive glass. Acta Biomater 2008, 4:1894-1903.
39. Lefebvre L., Chevalier J., Gremillard L., Zenati R., Thollet G., Bernache-Assolant D., et al. Structural transformations of bioactive glass 45S5 with thermal treatments. Acta Mater 2007, 55:3305-3313.
40. Erol M.M., Mourino V., Newby P., Chatzistavrou X., Roether J.A., Hupa L., et al. Copper-releasing, boron-containing bioactive glass-based scaffolds coated with alginate for bone tissue engineering. Acta Biomater 2012, 8:792-801.
41. Huang W., Wang Y.J., Ren L., Du C., Shi X.T. A novel PHBV/HA microsphere releasing system loaded with alendronate. Mater Sci Eng C: Mater Biol Appl 2009, 29:2221-2225.
42. Filho O.P., La Torre G.P., Hench L.L. Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res 1996, 30:509-514.
43. Zhu Y., Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous Mesoporous Mater 2009, 118:176-182.
44. Kim H.W., Knowles J.C., Kim H.E. Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 2004, 25:1279-1287.
45. Kim H.W., Knowles J.C., Kim H.E. Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B: Appl Biomater 2004, 70B:240-249.
46. Zhu X.H., Wang C.H., Tong Y.W. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A 2009, 89A:411-423.
47. Zhang L.F., Yang D.J., Chen H.C., Sun R., Xu L., Xiong Z.C., et al. An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture. Int J Pharm 2008, 353:74-87.
48. Olalde B., Garmendia N., Sáez-Martínez V., Argarate N., Nooeaid P., Morin F., et al. Multifunctional bioactive glass scaffolds coated with layers of poly(d,l-lactide-co-glycolide) and poly(n-isopropylacrylamide-co-acrylic acid) microgels loaded with vancomycin. Mater Sci Eng C: Mater Biol Appl 2013, 33:3760-3767.
49. Huang X., Brazel C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001, 73:121-136.